Technology Platforms
Bioinformatics
Bioinformatics Solutions to Accelerate Drug Discovery
Turning Omics Data into Actionable Insights
Our bioinformatics solutions help accelerate drug discovery by turning complex omics and genomics data into clear actionable insights. From early-stage research to mechanistic exploration, we empower your decision-making with interactive, intuitive data visualizations. Our platform enables you to:
- Identify and prioritize therapeutic targets
- Understand mechanisms of action (MoA), including both on- and off-target effects
- Discover and validate biomarkers for more precise patient stratification
- Repurpose drugs and expand therapeutic indications
- Make data-driven decisions on across diverse therapeutic modalities, including small molecules, biologics, and advanced therapies
Overcoming Challenges in Drug Discovery
While the demand for omics analysis is growing rapidly, interpreting complex and partially understood biological mechanisms remains the bottleneck for advancing translational research. Our bioinformatics framework is designed to address the following challenges:
- Difficulty linking genomic variants to functional disease mechanisms
- Lack of context-specific target prioritization
- Unclear MoA for phenotypic screening hits
- Sparse, noisy, or incomplete biomarker data
- Poor translatability of preclinical findings
- Mechanism and quality control challenges in cell therapy products
Why Choose Axcelead’s Bioinformatics:
- Experience of multi-layer omics data handling: genomics, transcriptomics, proteomics, metabolomics/lipidomics, epigenomics and ncRNAs.
- Leveraging our proprietary gene expression databases in combination with comprehensive public resources for genomic, phenotypic, and functional annotations to improve the prediction of disease mechanisms.
- Partnering with experts for advanced technology solutions (e.g., ATAC-seq, CITE-seq).
W
- Excellence in assay design and experimental strategy optimization.
- Delivering interactive visualizations for data-driven decisions.
- Generating publication-ready results to accelerate drug discovery.